Firm
Regulatory changes and damages risks are prompting Canadian firms and clients to opt for settlements in generic and biosimilar cases
A new claim filed by Ericsson, and a request for access to documents, were also among recent developments
Matthew Grady of Wolf Greenfield says AI presents an opportunity in patent practice for stronger collaboration between in-house and outside counsel
Discussion hosted by Bird & Bird partners also hears that UK courts’ desire to determine FRAND rates could see the jurisdiction penalised in a similar way to China
Sponsored
Sponsored
-
Sponsored by Gün and PartnersBarış Kalaycı and Direnç Bada of Gün and Partners assess the benefits of filing a criminal case based on trademark infringement for counterfeit products subject to the crime of smuggling -
Sponsored by RNA, Technology and IP AttorneysRanjan Narula of RNA, Technology and IP Attorneys takes a look at the new due diligence mechanism and considers why this has caused a backlash
-
Sponsored by Gorodissky & PartnersVladimir Biriulin of Gorodissky & Partners looks at why IP owners in Russia are increasingly satisfied with the outcome of disputes
-
Sponsored by Daniel LawKene Gallois and Guilherme Coutinho of Daniel Law explain how the success of the plan will pave the way for Brazil to attract further investment and opportunities
-
Sponsored by IncoproThe combination will accelerate tech innovation and provide a stronger, more united voice to help drive positive change in the online environment
-
Sponsored by CCPIT Patent and Trademark Law OfficeGang Hu of CCPIT Patent and Trademark Law Office discusses the Economic and Trade Agreement between China and the US regarding the protection of geographical indications
